2006 Midyear Clinical Meeting
Click here to go to the previous page
Beyond the Basics: The Pharmacists' Role in the Management of Osteoporosis
Track:
Sessions
Program Code: 262-L01
Date: Wednesday, December 6, 2006
Time: 8:00 AM to 10:00 AM
Location:
303C-D (CC)
MODERATOR:
Click the plus sign to see more detailed information about each speaker.
Eric MacLaughlin,
PharmD, BCPS, Associate Professor and Division Head of Adult Medicine,
Texas Tech School of Pharmacy
Eric MacLaughlin, Pharm.D., FCCP, BCPS is an Associate Professor and Division Head of Adult Medicine, Department of Pharmacy Practice at Texas Tech School of Pharmacy. He is also a Clinical Pharmacist with the Department of Family Medicine at Texas Tech School of Medicine. He received his B.S. in Pharmacy from Albany College of Pharmacy, Pharm.D. from the Medical University of South Carolina, and completed a Primary Care Specialty Residency at the University of Colorado. His practice interests include family medicine and outpatient geriatrics. Research interests include the treatment of hypertension, screening and treatment of osteoporosis, and pharmacy education.
|
SPEAKER(S):
Mary Beth Elliott, Pharm.D., Ph.D., Associate Professor and Pharmacy Practice Division Vice Chair, University of Wisconsin- Madison School of Pharmacy, Madison
Pharmacists? Role in Osteoporosis: From the Drugstore to the Clinic
Laura B. Hansen, Pharm.D., FCCP, BCPS, Assistant Professor, Department of Clinical Pharmacy and Family Medicine, University of Colorado Health Sciences Center, Denver, Colorado
Pharmacotherapy Management Update in Osteoporosis
Eric MacLaughlin,
PharmD, BCPS, Associate Professor and Division Head of Adult Medicine,
Texas Tech School of Pharmacy
Eric MacLaughlin, Pharm.D., FCCP, BCPS is an Associate Professor and Division Head of Adult Medicine, Department of Pharmacy Practice at Texas Tech School of Pharmacy. He is also a Clinical Pharmacist with the Department of Family Medicine at Texas Tech School of Medicine. He received his B.S. in Pharmacy from Albany College of Pharmacy, Pharm.D. from the Medical University of South Carolina, and completed a Primary Care Specialty Residency at the University of Colorado. His practice interests include family medicine and outpatient geriatrics. Research interests include the treatment of hypertension, screening and treatment of osteoporosis, and pharmacy education.
|
Impact of Osteoporosis and Related Fractures: Are We Missing the Boat?
Cynthia L. Raehl, Pharm.D., FASHP, FCCP, Chair, Clinical Research and Development, Department of Pharmacy Practice, Texas Tech University Health Sciences Center, School of Pharmacy, Amarillo
Treatment of Osteoporosis in Special Populations
Description
Learning Objectives:
Describe the medical and socioeconomic impact of osteoporosis and related fractures. Identify gaps between evidence and practice. Explain data which support various pharmacological interventions to increase bone mineral density and prevent fractures. Compare and contrast treatment recommendations for osteoporosis in different special populations. Describe the role of the pharmacist in screening, education, and management of osteoporosis.